(c) 2024 PillSync.com

nitroglycerin 0.4 mg

1 INDICATIONS AND USAGE Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Nitroglycerin sublingual tablets are nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. ( 1 )

glenmark pharmaceuticals inc., usa


4 years ago ROUND WHITE C 2 nitroglycerin 0.4 mg

ROUND WHITE C 2

16 HOW SUPPLIED/STORAGE AND HANDLING

NITROGLYCERIN Sublingual Tablets, USP are supplied as white to off white, round, flat-faced tablets in 3 strengths (0.3 mg, 0.4 mg, and 0.6 mg) in bottles containing 100 tablets each. The 0.4 mg strength is also supplied in Patient Convenience Packages of 4 bottles of 25 tablets each. 0.3 mg: debossed with “1” on one side and “C” on the other NDC 68462-638-01—Bottle of 100 tablets 0.4 mg: debossed with “2” on one side and “C” on the other NDC 68462-639-45—Convenience Package NDC 68462-639-01—Bottle of 100 tablets 0.6 mg: debossed with “3” on one side and “C” on the other NDC 68462-640-01—Bottle of 100 tablets Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].

NITROGLYCERIN should be kept in the original glass container and must be tightly capped after each use to prevent loss of tablet potency.


More pills like ROUND C 2

Related Pills

nitroglycerin 0.4 mg

glenmark pharmaceuticals inc., usa

nitroglycerin 0.6 mg

glenmark pharmaceuticals inc., usa

nitroglycerin 0.3 mg

glenmark pharmaceuticals inc., usa

clonazepam tablet

Accord Healthcare Inc.

clonazepam tablet

Accord Healthcare Inc.

Meloxicam meloxicam 7.5 MG Oral Tablet

International Labs, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site